We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue

Download Mobile App




In Other News

Image: At ASCO 2026, Natera’s oncology data program will feature 35 abstracts, including three oral presentations, focused on Signatera for pan-cancer MRD testing and the Treatment on MRD approach

Natera to Present Data on MRD-Guided Cancer Care at ASCO 2026

Natera, Inc. (Austin, TX, USA), a company focused on cell-free DNA testing and precision medicine, announced an oncology data program for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29–June 2 in Chicago. Read more
26 May 2026 | Industry
Image: Fujifilm’s Synapse Pathology is a comprehensive pathology PACS that streamlines case management through proprietary advances in image digitization (photo courtesy of Fujifilm)

Fujifilm Integrates Structured Reporting into Digital Pathology Workflow

FUJIFILM Healthcare Americas Corporation (Lexington, MA, USA) and mTuitive (Centerville, MA, USA) have formed a strategic partnership to integrate mTuitive’s structured pathology reporting platform with Fujifilm’s Synapse Pathology. Read more
26 May 2026 | Industry
Evan P. Kransdorf et al., Population-Based Analysis of Rare Genetic Variants in Sudden Cardiac Arrest, JACC: Clinical Electrophysiology (2026). DOI: 10.1016/j.jacep.2026.03.016

Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals

Sudden cardiac arrest (SCA) is a frequently fatal electrical failure of the heart that is difficult to predict, as most victims have no prior warning signs. Read more
23 May 2026 | BioResearch
Image: New findings suggest that standard “normal” CA19-9 cutoffs may mask aggressive disease in nonproducers, while a dual-threshold model could reduce misinterpretation (image credit: Adobe Stock)

New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients

Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed at an advanced stage and remains one of the most lethal solid tumors. Read more
22 May 2026 | Clinical Chem.
Image: Seegene’s Allplex MDRO Assay is designed to support detection of multidrug-resistant organisms (MDROs) (Photo courtesy of Seegene)

New AMR Assay Supports Rapid Infection Control Screening in Hospitals

As antimicrobial resistance spreads worldwide, healthcare-associated infections are placing a growing burden on hospitals, increasing the need for faster and broader diagnostic solutions. Read more
22 May 2026 | Microbiology
Image: Graphical Abstract (Crotts S.B., Barnes J.T., Antonetti R.M., et al. Cell Reports (2026). DOI:10.1016/j.celrep.2026.117347)

Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Read more
22 May 2026 | Immunology
Image: The study’s findings may help identify iron deficiency earlier in children aged 5 to 14 years.(Photo courtesy of iStock)

Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children

Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia. Read more
22 May 2026 | Hematology
Image: The approach aims to complement symptom-based clinical assessments for psychosis with quantifiable molecular readouts (photo courtesy of Shutterstock)

Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction

Psychosis commonly emerges in adolescence or early adulthood and can severely disrupt social and occupational functioning. Read more
22 May 2026 | Clinical Chem.
Image: A member of the WHO Ebola ring vaccination team vaccinates a man in Bosolo village during a 2018 Ebola outbreak in Congo (Photo courtesy of WHO/Lindsay Mackenzie)

Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo

In eastern Democratic Republic of the Congo, communities are confronting a resurgence of Bundibugyo ebolavirus, a rarer species for which no vaccines or treatments have been approved. Read more
21 May 2026 | Microbiology
Image: The new Guardant360 Liquid CDx assay measures a 100‑fold wider genomic footprint than the previously approved Guardant360 CDx (Photo courtesy of Guardant Health)

FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling

Timely, comprehensive tumor profiling helps clinicians make treatment selection decisions for patients with advanced cancer. Read more
21 May 2026 | Molecular Diagnostics
Image: QIA Agent is an AI-powered digital assistant designed to help users plan experiments, identify suitable products, access technical information, and manage ordering through a single interface (Photo courtesy of Qiagen)

AI-Enabled Assistant Unifies Molecular Workflow Planning and Support

Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. Read more
21 May 2026 | Technology
Image: The initiative will generate long‑read bulk RNA‑sequencing datasets to advance patient‑level prediction from tumor transcriptomes and support applications in biomarkers, clinical trial design, and diagnostics (Image courtesy of BlankBio)

Strategic Collaboration Advances RNA Foundation Models for Precision Oncology

Bulk RNA sequencing is increasingly used to study tumor biology, but standard analyses often reduce results to gene-level summaries that miss important transcript variants and mutation patterns. Read more
21 May 2026 | Industry
Image: The approach profiles bacteria in saliva and applies machine-learning algorithms to distinguish patients with ESCC from unaffected controls (image credit: Adobe Stock)

Microbial Saliva Test Could Help Triage Esophageal Cancer Risk

Esophageal squamous cell carcinoma (ESCC) is highly lethal, partly because many patients are diagnosed only after swallowing becomes difficult and treatment options are largely palliative. Read more
21 May 2026 | Molecular Diagnostics
Image: McGill researchers identified a centuries-old “jumping gene” mutation that helps explain elevated pancreatic cancer risk among some French-Canadians in Quebec (image credit: 123RF)

Hidden 'Jumping Gene' Variant Linked to Higher Pancreatic Cancer Risk

Pancreatic cancer risk among some French-Canadians in Quebec has been difficult to explain, as conventional genetic workups have often failed to identify inherited drivers. Read more
21 May 2026 | BioResearch

Channels

Clinical Chemistry

view channel
Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Image: For decades, laboratories have adjusted total calcium for albumin, but growing evidence shows these corrections often perform poorly and may cause harm (image credit: iStock)

International Experts Recommend Ending Routine 'Corrected' Calcium Reporting

Interpreting serum calcium can be clinically challenging when albumin levels vary, especially in patients with chronic illness or kidney disease. For decades, laboratories have used formulas to adjust... Read more

Molecular Diagnostics

view channel
Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cance...
New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy
Breast Cancer-Specific Signatures Link Genome Instability to Outcomes
Image: The original Yourgene DPYD test has been enhanced to detect 19 variants, including 14 recommended by updated guidelines and five additional variants for broader global coverage (photo courtesy of Yourgene Health)

Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing

Fluoropyrimidines such as 5-fluorouracil (5-FU) are chemotherapy drugs prescribed to more than two million cancer patients each year, but 10–20% of patients can experience severe, and sometimes fatal,... Read more

Hematology

view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
Image: Graphical abstract (Waclawiczek A, Leppä AM, Renders S, et al. Cell Stem Cell, 2026. doi:10.1016/j.stem.2026.04.012)

Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more

Immunology

view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Biomarkers and Molecular Testing Advance Precision Allergy Care
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Image: The novel blood test could replace invasive biopsies for detecting acute cellular rejection after lung transplantation (image credit: 123RF)

Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring

Lung transplant recipients face some of the highest rates of acute cellular rejection, and routine surveillance often relies on repeated surgical biopsies. These procedures can cause complications such... Read more

Microbiology

view channel
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospi...
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized...
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more

Pathology

view channel
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratificati...
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Image: Graphical Abstract (Eldad D. Shulman et al., AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathology, Cell (2026). DOI: 10.1016/j.cell.2026.04.023)

Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images

Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more

Technology

view channel
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Di...
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
Image: Labbit is a modern LIMS platform designed for regulated laboratories managing complex workflows in molecular diagnostics, cell and gene therapy, and quality control manufacturing (photo courtesy of Labbit)

AI Tool Automates Validation of Laboratory Software Configuration Changes

Regulated laboratories face heavy documentation and requalification demands when software configurations change, slowing improvements and discouraging beneficial updates. A new capability now automates... Read more

Industry

view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Partnership Aims to Bring Risk-Guided CKD Care to Health Systems
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Por...
Image: Gustave Roussy is partnering with One Biosciences, a techbio company using single-cell technology and AI to advance precision diagnostics

Partnership Brings Single-Cell Analysis into Clinical Oncology Workflows

Selecting treatments for advanced cancer remains difficult when bulk analyses mask the functional diversity of tumor cells and mechanisms of resistance that emerge over time. Clinicians increasingly need... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE